2009
DOI: 10.1370/afm.870
|View full text |Cite
|
Sign up to set email alerts
|

Lack of Impact of Direct-to-Consumer Advertising on the Physician-Patient Encounter in Primary Care: A SNOCAP Report

Abstract: PURPOSE Direct-to-consumer advertising (DTCA) has increased tremendously during the past decade. Recent changes in the DTCA environment may have affected its impact on clinical encounters. Our objective was to determine the rate of patient medication inquiries and their infl uence on clinical encounters in primary care. METHODSOur methods consisted of a cross-sectional survey in the State Networks of Colorado Ambulatory Practices and Partners, a collaboration of 3 practice-based research networks. Clinicians c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
48
0
1

Year Published

2009
2009
2018
2018

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(51 citation statements)
references
References 13 publications
2
48
0
1
Order By: Relevance
“…Another SNOCAP study examined direct-to-consumer advertising. 21 During 1 day of patient care, the clinician completed a card for every patient seen. If the patient requested a medication during the visit, the clinician completed the entire card; otherwise, the clinician completed just the basic patient demographics.…”
Section: A R D S T Udies F or Observat Iona L R Ese A Rchmentioning
confidence: 99%
“…Another SNOCAP study examined direct-to-consumer advertising. 21 During 1 day of patient care, the clinician completed a card for every patient seen. If the patient requested a medication during the visit, the clinician completed the entire card; otherwise, the clinician completed just the basic patient demographics.…”
Section: A R D S T Udies F or Observat Iona L R Ese A Rchmentioning
confidence: 99%
“…• Overcoming fragmented health care 12 • Refocusing generalists and specialists on their most effective and effi cient roles and shared care 13 • Using listening and relationship rather than tests to foster a sense of patient well-being 14 • Implementing incentives so that they do more good than harm 15 • Improving maternity care access and comprehensiveness 16,17 • Reframing our interpretation of the effect of personality on study data completeness 18 • Making the cholesterol-lowering benefi ts of barley tolerable 19 • Improving quality of care 20 • Improving communication with a pause during care and by reforming care away from only brief encounters 21 • Understanding how important health literacy is to effective health care 22 • Approaching the multifactorial nature of asthma and its multilevel treatment 23 • Overcoming underrecognition of the impact of direct-to-consumer advertising on the outpatient visit and prescribing 24 • Fanning or slaking turf wars around who should perform colonoscopy 25 • Assessing the trade-offs involved in using short or long instruments to screen for postpartum depression 26 • Implementing processes for detecting and managing post-myocardial infarction depression 27 • Reconsidering relevancy and bureaucratic load of the National Committee for Quality Assurance assessment of the patient-centered medical home concept 28 • Understanding uncertainty 29 • Considering the trade-offs in paper vs electronic data collection in offi ce-based research 30 We were delighted to see the comments of a residency journal club. 31 We encourage other local journal clubs, and all readers, to join the discussion at http:// www.AnnFamMed.org…”
Section: More Highlightsmentioning
confidence: 99%
“…Proponents of DTCA state that the advertisements provide consumers with valuable educational information that can bring financial and health related benefits. 2,3 Opponents of DTCA state that the advertisements provide consumers with incomplete and biased information that may generate unnecessary visits and inappropriate requests for medications. 1,3 In the midst of these debates, the Food and Drug Administration (FDA) created guidelines to regulate DTCA.…”
Section: Introductionmentioning
confidence: 99%
“…2,3 Opponents of DTCA state that the advertisements provide consumers with incomplete and biased information that may generate unnecessary visits and inappropriate requests for medications. 1,3 In the midst of these debates, the Food and Drug Administration (FDA) created guidelines to regulate DTCA. Within the guidelines, the presentation of a fair balance between benefit and risk information in DTCA is considered to be a fundamental component because the FDA believes that consumers are more likely able to make informed and conscious evaluations and decisions when they are presented with both sides of the information.…”
Section: Introductionmentioning
confidence: 99%